Key result
Higher ECT seizure quality was associated with a decrease in depressive symptomatology, while 61.5% of patients with poor-quality seizures relapsed at 1 month.
Why the study?
Do ECT seizure quality markers predict treatment response in patients with treatment-resistant depression?
Observational (n=45)
Double-blind
Do ECT seizure quality markers predict treatment response in patients with treatment-resistant depression?
ECT seizure quality markers, particularly hemispheric brain wave synchronicity and wave amplitude, are strongly correlated with the decrease of depressive symptomatology in treatment-resistant depression.
Answers are grounded in this paper and cite their sources.
ECT seizure quality markers may predict response in resistant depression; hypothesis-generating pending randomized trials.
OBJECTIVES: Electroconvulsive therapy (ECT) is the most effective therapy for patients with treatment-resistant depression; however, some patients do not respond or relapse in a short time. Electroconvulsive therapy stimulus parameters may be related to the outcome. We carried out a retrospective study review to investigate various ECT parameters in relation to the outcome, clinical variables, and pharmacological treatments. Our aim was to understand which factors could be considered putative seizure quality markers and which are relevant to clinical practice. METHODS: Two physicians evaluated the seizure length, the postictal suppression index, the wave amplitude, tachycardia, and hemispheric brain wave synchronicity in a double-blind manner for 45 treatment-resistant depression patients receiving ECT. RESULTS: The analysis showed a significant association between the outcome and the ECT seizure quality measured by the parameters (P = 9.9 × 10). Among patients with poor-quality seizures, 61.5% relapsed after approximately 1 month from the last ECT session. Particularly, there was an association between higher symptomatology decrease and higher quality of hemispheric brain wave synchronicity (P = 5.0 × 10), as well as a higher wave amplitude (P = 0.01). CONCLUSIONS: Our results confirm that ECT seizure quality was strongly correlated with the decrease of depressive symptomatology.
No takes yet. Share an insight, caveat, or question.
Minelli et al. (2015) conducted an observational in Treatment-resistant depression (n=45). ECT seizure quality vs. Poor-quality seizures was evaluated on Decrease of depressive symptomatology (p=9.9 × 10). Higher ECT seizure quality was associated with a decrease in depressive symptomatology, while 61.5% of patients with poor-quality seizures relapsed at 1 month.
Synapse has enriched 10 related papers. Consider them for comparative context: